$Prolonged Survival Outcome in a Patient with Refractory Metastatic Colorectal Cancer Treated with Regorafenib Plus 5-Fluorouracil: A Case Report and Literature Review$

Prolonged Survival Outcome in a Patient with Refractory Metastatic Colorectal Cancer Treated with Regorafenib Plus 5-Fluorouracil: A Case Report and Literature Review

<b>Background:</b> The use of regorafenib and 5-fluorouracil in the management of refractory metastatic colorectal cancer has gained increasing attention due to their demonstrated efficacy in extending the survival of patients with colorectal cancer. This study aims to discuss the effect...

Full description

Saved in:

Bibliographic Details
Main Authors:	Abdullah Esmail, Bayan Khasawneh, Ebtesam Al-Najjar, Raed Zaidan, Maen Abdelrahim
Format:	Article
Language:	English
Published:	MDPI AG 2025-04-01
Series:	Reports
Subjects:	colorectal cancer metastasis case report regorafenib 5-fluorouracil 5-FU
Online Access:	https://www.mdpi.com/2571-841X/8/2/59
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Safety and Efficacy of Regorafenib and 5-Fluorouracil Combination Therapy in Refractory Metastatic Colorectal Cancer After Third-Line Treatment: An Institutional Experience
by: Maen Abdelrahim, et al.
Published: (2025-05-01)

Topical 5-fluorouracil application in management of odontogenic keratocysts
by: Parveen Akhter Lone, et al.
Published: (2020-10-01)

Repigmentation of vitiligo with 5-fluorouracil tattooing in combination with topical ruxolitinib: A case report
by: Betul Macit, MD, et al.
Published: (2025-04-01)

Kepingan Es Sebagai Cryotherapy untuk Mengobati Mukositis Pada Pasien Kanker Kolon Yang Menjalani Kemoterapi Regimen Fluorouracil (5FU)
by: Trisnowati Uji, et al.
Published: (2025-07-01)

PERBANDINGAN KEJADIAN LEUKOPENIA DAN TROMBOSITOPENIA PADA PENDERTIA KARSINOMA NASOFARING YANG MENDAPATKAN KEMOTERAPI PACLITAXEL CISPLATIN DAN CISPLATIN 5-FLUOROURACIL (5-FU)
by: Nadya Tara Audina, et al.
Published: (2019-10-01)

Modulation of the tumor microenvironment by zerumbone and 5-fluorouracil in colorectal cancer by target in cancer-associated fibroblasts
by: Sima Nobari, et al.
Published: (2025-04-01)

Synthesis of 5-Fluorouracil (5-FU) coated platinum nanoparticles and apoptotic effects on U87 human glioblastoma cells
by: Atena Abed, et al.
Published: (2025-07-01)

More subtle microsatellite instability better predicts fluorouracil insensitivity in colorectal cancer patients
by: Kaname Miyashita, et al.
Published: (2024-11-01)

Improving the drug delivery performance of ZIF-8 with amine functionalization as a 5-fluorouracil nanocarrier
by: Sahba Mirzanejad, et al.
Published: (2025-05-01)

Shouhui Tongbian Capsule ameliorates 5-fluorouracil induced constipation in mice by modulating gut microbiota and activating PI3K/AKT/AQP3 signaling pathway
by: Yawei Zhang, et al.
Published: (2025-07-01)

Analysis of the Efficacy of 5-Fluorouracil in the Treatment of Invasive Moles
by: Chunhua Liu, et al.
Published: (2024-03-01)

5-Fluorouracil-Induced Leukoencephalopathy: Report of Two Cases and Review of Literature
by: Supreeth RN, et al.
Published: (2024-12-01)

Investigation of Ototoxicity of Intratympanic 5-fluorouracil in Rats
by: Meltem Demirdağ Çevikkan, et al.
Published: (2022-12-01)

The efficacy of regorafenib monotherapy as the third-and later-line treatment for metastatic colorectal cancer: a retrospective study
by: An Tianqi, et al.
Published: (2022-08-01)

Successful desensitization with 5-fluorouracil in a patient who developed anaphylaxis after 5-fluorouracil infusion
by: Mehmet Erdem Çakmak, et al.
Published: (2024-08-01)

Effcacy and toxicity of regorafenib compared to reintrodaction of chemotherapy in metastatic colon cancer: retrospective multicenter study
by: E. S. Kuzmina, et al.
Published: (2023-09-01)

5-Fluorouracil-Induced Hepatic Perturbation: Protective Potential of Selenium
by: Elias Adikwu, et al.
Published: (2020-01-01)

DETERMINATION OF CAPECITABINE AND ITS ACTIVE METABOLITE 5-FLUOROURACIL IN BLOOD PLASMA BY HPLC-MS/MS
by: E. S. Melnikov, et al.
Published: (2019-01-01)

Chemistry of Secondary Metabolites (Production, Properties, Biological Activity, etc.): Solubility Study of the Interaction between Pamam G-3 Dendrimer and 5 Fluorouracil in Aqueous Solution
by: B. PALECZ, et al.
Published: (2016-07-01)

Chemistry of Secondary Metabolites (Production, Properties, Biological Activity, etc.): Solubility Study of the Interaction between Pamam G-3 Dendrimer and 5 Fluorouracil in Aqueous Solution
by: B. PALECZ, et al.
Published: (2014-06-01)

Chemistry of Secondary Metabolites (Production, Properties, Biological Activity, etc.): Solubility Study of the Interaction between Pamam G-3 Dendrimer and 5 Fluorouracil in Aqueous Solution
by: B. PALECZ, et al.
Published: (2014-07-01)

Caspase Gene Expression in Colon Cancer Cells Exposed to 5-Fluorouracil Treatment
by: Jelena Pavić, et al.
Published: (2024-04-01)

Preoperative chemotherapy with docetaxel, cisplatin, and 5-fluorouracil for locally advanced esophageal carcinosarcoma: a case report and review of the literature
by: Tomoko Yoshimoto, et al.
Published: (2018-02-01)

Efficacy of Thymoquinone and Hesperidin in Attenuating Cardiotoxicity from 5-Fluorouracil: Insights from In Vivo and In Silico Studies
by: Juveriya Farooq, et al.
Published: (2024-09-01)

SPARC Promotes Aerobic Glycolysis and 5‐Fluorouracil Resistance in Colorectal Cancer Through the STAT3/HK2 Axis
by: Jingrong Xiang, et al.
Published: (2025-06-01)

Combination Therapy of 5-Fluorouracil and Triamcinolone Acetonide with Compression Therapy after Surgical Excision in the Management of Keloids in Ears
by: Randeep Singh Lamba, et al.
Published: (2025-04-01)

A Pharmacokinetic Study of the Interaction Between Regorafenib and Paracetamol in Male Rats
by: Agnieszka Karbownik, et al.
Published: (2024-10-01)

Unlocking Better Keloid Treatment: Corticosteroid, 5‐Fluorouracil, and Hyaluronidase vs. Corticosteroid Alone – A Randomized Comparative Study
by: Ala Ehsani, et al.
Published: (2025-05-01)

A Green, Solvent- and Cation-Free Approach for Preparing 5-Fluorouracil-Loaded Alginate Nanoparticles Using Microfluidic Technology
by: Abdolelah Jaradat, et al.
Published: (2025-03-01)

Chitosan nanocarriers: Pioneering encapsulation and targeted delivery of 5-fluorouracil - A comprehensive review
by: Mariyeh Rajaei, et al.
Published: (2024-12-01)

Ameliorative effects of Berberine chloride against 5-fluorouracil-induced cardiotoxicity in Sprague Dawley rats
by: Mirna Akram Labib, et al.
Published: (2025-08-01)

Cyclodextrin nanocarriers in Coordination Chemistry: Enhancing encapsulation and targeted delivery of 5-Fluorouracil for cancer treatment
by: Sara Payamifar, et al.
Published: (2024-12-01)

Cardioprotective effects of dapagliflozin against the acute cardiotoxic effects of 5-fluorouracil
by: Mehmet Hakan Uzun, et al.
Published: (2025-07-01)

Salidroside enhances 5-fluorouracil sensitivity against hepatocellular carcinoma via YIPF5-induced mitophagy
by: Sumin Sun, et al.
Published: (2025-01-01)

Hepatoprotective effect of Nobiletin against 5-fluorouracil induce hepatotoxicity
by: Safa A. Yahya, et al.
Published: (2024-01-01)

Genetic variants and clinical determinants affecting the response to 5-Fluorouracil-based treatment in Chilean patients with advanced colorectal cancer
by: Leslie C. Cerpa, et al.
Published: (2025-07-01)

5-Fluorouracil Impairs Transmission of Acetylcholine in the Hippocampus and Induces Cognitive Impairments in Mice
by: Xiwen Huang, et al.
Published: (2025-04-01)

Anticancer and Antiproliferative Effects of Combined Treatment with 5-Fluorouracil and Probiotic Lactobacillus Strains against Colorectal Cancer Cells
by: Sanaz Salek, et al.
Published: (2024-12-01)

Comparative Evaluation of the Preventive Effects of Citral, Silymarin, Thymoquinone, and Curcumin on 5-Fluorouracil-Induced Cardiac and Pulmonary Toxicity in Rats
by: Tohid Zahed, et al.
Published: (2024-12-01)

<i>Bacillus clausii</i> Attenuates 5-Fluorouracil-Induced Intestinal Mucositis in Mice
by: Francisco Ronaldo Farias Lima, et al.
Published: (2024-12-01)